Interleukin-1 inhibits Sox9 and collagen type II expression via nuclear factor-κB in the cultured human intervertebral disc cells

Chinese Medical Journal

Volumn 122, Issue 20, 2009, Pages 2483-2488

  Yu, Zhan Ge ^a   Xu, Ning ^a   Wang, Wen Bo ^a   Pan, Shang Ha ^a   Li, Ke Shen ^b   Liu, Jia Kun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN ENGINEERING UNIVERSITY   (China)

Author keywords

Collagen type II; Interleukin 1; Intervertebral disc cells; Nuclear factor B; Sox9

Indexed keywords

COLLAGEN TYPE 2; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MESSENGER RNA; TRANSCRIPTION FACTOR SOX9;

ADULT; ARTICLE; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INTERVERTEBRAL DISK; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; CELLS, CULTURED; COLLAGEN TYPE II; CURCUMIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-1; INTERVERTEBRAL DISK; MALE; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOX9 TRANSCRIPTION FACTOR;

EID: 70350707944     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.20.016     Document Type: Article

References (30)

1. Paul R, Haydon RC, Cheng H, Ishikawa A, Nenadovich N, Jiang W, et al. Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine 2003; 28: 755-763. (Pubitemid 36459290)
2. Lefebvre V, de Crombrugghe B. Toward understanding SOX9 function in chondrocyte differentiation. Matrix Biol 1998; 16: 529-540. (Pubitemid 28165732)
3. Zhao Q, Eberspaecher H, Lefebvre V, de Crombrugghe B. Parallel expression of sox9 and col2a1 in cells undergoing chondrogenesis. Dev Dyn 1997; 209: 377-386. (Pubitemid 27328464)
4. Hering TM. Regulation of chondrocyte gene expression. Front Biosci 1999; 4: D743-D761.
5. Sive JI, Baird P, Jeziorsk M, Watkins A, Hoyland JA, Freemont AJ. Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol 2002; 55: 91-97. (Pubitemid 34293410)
6. Gruber HE, Norton HJ, Ingram JA, Hanley EN Jr. The SOX9 transcription factor in the human disc: Decreased immunolocalization with age and disc degeneration. Spine 2005; 30: 625-630.
7. Antoniou J, Steffen T, Nelson F, Winterbottom N, Hollander AP, Poole RA, et al. The human lumbar intervertebral disc: Evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest 1996; 98: 996-1003. (Pubitemid 26293318)
8. Buckwalter JA. Aging and degeneration of the human intervertebral disc. Spine 1995; 20: 1307-1314.
9. Nerlich AG, Schleicher ED, Boos N. 1997 Volvo Award winner in basic science studies. Immunohistologic markers for age-related changes of human lumbar intervertebral discs. Spine 1997; 22: 2781-2795.
10. Grönblad M, Virri J, Tolonen J, Seitsalo S, Kääpä E, Kankare J, et al. A controlled immunohistochemical study of inflammatory cells in disc herniation tissue. Spine 1994; 19: 2744-2751.
11. Pelletier JP, DiBattista JA, Roughley P, McCollum R, Martel-Pelletier J. Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 1993; 19: 545-568.
12. Hamilton JA, Hart PH, Leizer T, Vitti GF, Campbell IK. Regulation of plasminogen activator activity in arthritic joints. J Rheumatol Suppl 1991; 27: 106-109.
13. Goldring MB, Fukuo K, Birkhead JR, Dudek E, Sandell LJ. Transcriptional suppression by interleukin-1 and interferon-gamma of type II collagen gene expression in human chondrocytes. J Cell Biochem 1994; 54: 85-99. (Pubitemid 24073736)
14. Largo R, Alvarez-Soria MA, Diez-Ortego I, Calvo E, Sanchez-Pernaute O, Egido J, et al. Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondroctyes. Osteoarthritis Cartilage 2003; 11: 290-298. (Pubitemid 36410882)
15. Murakami S, Lefebvre V, de Crombrugghe B. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. J Biol Chem 2000; 275: 3687-3692. (Pubitemid 30083081)
16. Thompson JP, Pearce RH, Schechter MT, Adams ME, Tsang IK, Bishop PB. Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc. Spine 1990; 15: 411-415.
17. Tim Yoon S, Su Kim K, Li J, Soo Park J, Akamaru T, Elmer WA, et al. The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro. Spine 2003; 28: 1773-1780. (Pubitemid 37012751)
18. Li Y, Tew SR, Russell AM, Gonzalez KR, Hardingham TE, Hawkins RE. Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. Tissue Eng 2004; 10: 575-584.
19. Aigner T, Gebhard PM, Schmid E, Bau B, Harley V, Poschi E. SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol 2003; 22: 363-372. (Pubitemid 36993761)
20. Zhao Z, Wang WB, Li JY, Liu Y, Li XS, Ma SQ. Correlation in gene expression between Sox9 and collagen type II in human intervertebral disc nucleus pulposus cells. Chin J Spine Spinal Cord (Chin) 2007; 5: 384-387.
21. Zhang N, Cui HD, Xue HX. Effect of local viral transfer of interleukin 10 gene on a rabbit arthritis model induced by interleukin 1β. Chin Med J 2008; 121: 435-438. (Pubitemid 351565991)
22. Robbins JR, Thomas B, Tan L, Choy B, Arbiser JL, Berenbaum F, et al. Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta. Arthritis Rheum 2000; 43: 2189-2201. (Pubitemid 30783137)
23. Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Donaldson WF 3rd, Evans CH. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 1996; 21: 271-277.
24. Bu PL, Zhao XQ, Wang LL, Zhao YX, Li CB, Zhang Y. Tong-xin-luo capsule inhibits left ventricular remodeling in spontaneously hypertensive rats by enhancing PPAR-γ expression and suppressing NF-κB activity. Chin Med J 2008; 121: 147-154. (Pubitemid 351247889)
25. Wang HY, Yang YM, Zhuang Y, Chen HN, Wan YL, Huang YT. The effect of celecoxib on tissue factor expression in pancreatic cancer cells. Chin Med J 2007; 120: 1753-1756. (Pubitemid 350111077)
26. Xue DB, Zhang WH, Yun XG, Song C, Zheng B, Shi XY, et al. Regulating effects of arsenic trioxide on cell death pathways and inflammatory reactions of pancreatic acinar cells in rats. Chin Med J 2007; 120: 690-695. (Pubitemid 46767805)
27. Hu YH, Yu LJ, Shao ED, Wu JL, Ji JW. The regulating role of mutant IκBα in expression of TIMP-2 and MMP-9 in human glioblastoma multiform. Chin Med J 2009; 122: 205-211.
28. Lin JK, Pan MH, Lin-Shiau SY. Recent studies on the biofunctions and biotransformations of curcumin. Biofactors 2000; 13: 153-158.
29. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-780.
30. Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappaB and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 2003; 101: 1053-1062. (Pubitemid 36139379)